TIMKEN US CORPORATION – Trademark Portfolio
Entity Type: 03
TIMKEN US CORPORATION holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 7 (Machinery) — 7 filings in this category. The portfolio also extends into Class 6 (Metal Goods) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include FAFNIR, SURVIVOR, and TORRINGTON. The owner is based in WILMINGTON, DE.
SUITE 400
2711 CENTERVILLE ROAD
WILMINGTON, DE 19808
Showing of trademarks Trademarks
Trademark Classifications
TIMKEN US CORPORATION's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Machines and machine tools; motors and engines; machine coupling and transmission components
Common metals and their alloys; metal building materials; transportable buildings of metal
Industrial oils and greases; lubricants; dust absorbing, wetting and binding compositions
Frequently Asked Questions
How many trademarks does TIMKEN US CORPORATION have?
TIMKEN US CORPORATION has 9 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 abandoned, 4 cancelled.
What trademark classes does TIMKEN US CORPORATION file in?
TIMKEN US CORPORATION files trademarks across 3 Nice Classification classes. The most active classes are Class 7 (Machinery), Class 6 (Metal Goods), Class 4 (Lubricants & Fuels). Class 7 covers machines and machine tools; motors and engines; machine coupling and transmission components.
What are TIMKEN US CORPORATION's most well-known trademarks?
TIMKEN US CORPORATION's registered trademark portfolio includes well-known marks such as FAFNIR, SURVIVOR, and TORRINGTON. These are among 3 currently registered trademarks in the portfolio.
What is TIMKEN US CORPORATION's trademark registration success rate?
TIMKEN US CORPORATION has a 33% trademark registration rate, with 3 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.